Tenaya Therapeutics Ownership | Who Owns Tenaya Therapeutics?

Tenaya Therapeutics Ownership Summary

Tenaya Therapeutics is owned by 19.39% institutional investors, 0.70% insiders, and 79.90% retail investors. Column group is the largest institutional shareholder, holding 10.91% of TNYA shares. US Small-Cap Growth II Equity Comp is the top mutual fund, with 2.66% of its assets in Tenaya Therapeutics shares.

TNYA Ownership Benchmark

Type	Name	% Inst	% Insiders	% Retail
Stock	Tenaya Therapeutics	19.39%	0.70%	79.90%
Sector	Healthcare Stocks	487.91%	11.08%	-398.99%
Industry	Biotech Stocks	307.10%	11.11%	-218.21%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

Holder	Shares	% Holding	Value
Column group	9.40M	10.91%	$13.44M
Blackrock	4.07M	5.03%	$12.63M
Vanguard group	3.27M	3.80%	$4.68M
Blackrock funding, inc. /de	2.73M	1.68%	$1.67M
Ghost tree capital	1.35M	1.67%	$4.18M
Geode capital management	1.27M	1.47%	$1.81M
State street	1.05M	1.30%	$3.25M
Euclidean capital	1.02M	0.62%	$620.80K
Alphabet	915.71K	0.56%	$558.58K
Ubs group	478.51K	0.56%	$684.27K

Top Institutional Shareholders by % of Total Assets

Holder	Shares	% Assets	Value
Column group	9.40M	24.12%	$13.44M
Ghost tree capital	1.35M	1.31%	$4.18M
Stepstone group lp	462.16K	0.56%	$282.38K
Euclidean capital	1.02M	0.20%	$620.80K
Trustees of columbia university in the city of new york	291.83K	0.03%	$166.34K
Alphabet	915.71K	0.03%	$558.58K
Casdin capital	361.97K	0.02%	$221.24K
Parkwoods wealth partners	15.00K	0.01%	$24.30K
Virtu financial	104.71K	0.01%	$150.00K
Atticus wealth management	47.80K	0.01%	$29.22K

Top Buyers

Holder	Shares	% Assets	Change
Ghost tree capital	1.35M	1.31%	575.00K
Ubs group	478.51K	0.00%	452.37K
Marshall wace, llp	148.09K	0.00%	148.09K
Susquehanna group, llp	146.76K	-	136.42K
Virtu financial	104.71K	0.01%	104.71K

Top Sellers

Holder	Shares	% Assets	Change
Ra capital management	-	-	-6.98M
Casdin capital	361.97K	0.02%	-6.37M
Woodline partners lp	-	-	-5.92M
Price t rowe associates inc /md/	136.23K	-	-2.89M
Octagon capital advisors lp	-	-	-2.58M

New Positions

Holder	Shares	% Assets	Change	Value
Marshall wace, llp	148.09K	0.00%	148.09K	$90.33K
Point72 asia (singapore) pte.	35.02K	0.00%	35.02K	$21.41K
Hrt financial lp	34.31K	0.00%	34.31K	$20.00K
Ewa	29.66K	0.01%	29.66K	$18.13K
Kestra private wealth services	22.00K	0.00%	22.00K	$13.45K

Sold Out

Holder	Change
Nelson, van denburg & campbell wealth management group	-11.00
Capital performance advisors llp	-12.00
Advisor group	-38.00
Srs capital advisors	-105.00
Federated hermes	-414.00

Institutional Ownership Trends

Date	Holdings	Change %	Shares	Change %	Ownership	Change %	Increased Position	Change %	Decreased Position	Change %
Jun 30, 2025	91	-14.95%	31,571,278	-34.46%	19	1.01%	44	-16.98%	25	-21.88%
Mar 31, 2025	2	-97.70%	32,748	-99.92%	-	0.00%	1	-97.92%	1	-94.74%
Dec 31, 2024	49	-47.31%	18,984,954	-67.06%	22	0.49%	29	-43.14%	9	-47.06%
Sep 30, 2024	93	-3.13%	57,630,897	1.33%	66	1.36%	51	-5.56%	17	-37.04%
Jun 30, 2024	96	6.67%	56,876,265	1.89%	70	1.23%	54	12.50%	27	3.85%

Top Mutual Funds Shareholders

Holder	Shares	% Holding	Change
US Small-Cap Growth II Equity Comp	2.10M	2.66%	-471.71K
T. Rowe Price New Horizons	2.10M	2.65%	-441.00
Fidelity Select Biotechnology	1.75M	2.20%	-
Vanguard Total Stock Mkt Idx Inv	2.82M	1.73%	-62.29K
JPMorgan US Small Company L	785.69K	0.91%	-315.70K
Vanguard Institutional Extnd Mkt Idx Tr	1.23M	0.76%	-562.30K
T. Rowe Price New Horizons Tr-Z	554.73K	0.70%	9.11K
Fidelity Small Cap Index	608.02K	0.37%	-
abrdn Life Sciences Investors	600.70K	0.37%	-
BlackRock Health Sciences Term Trust	291.39K	0.37%	-120.40K

Recent Insider Transactions

Date	Name	Role	Activity	Value
Aug 18, 2025	Higa Tomohiro	SVP, Finance	Sell	$655.32
Aug 18, 2025	Higa Tomohiro	SVP, Finance	Sell	$2.16K
Aug 18, 2025	Higa Tomohiro	SVP, Finance	Sell	$898.40
Aug 18, 2025	Tingley Whittemore	Chief Medical Officer	Sell	$2.01K
Aug 18, 2025	Tingley Whittemore	Chief Medical Officer	Sell	$2.01K

Insider Transactions Trends

Date	Buy	Sell
2025 Q3	-	9
2025 Q2	-	3
2025 Q1	6	8
2024 Q4	-	1
2024 Q3	-	7

TNYA Ownership FAQ

Who Owns Tenaya Therapeutics?

Tenaya Therapeutics shareholders are primarily institutional investors at 19.39%, followed by 0.70% insiders and 79.91% retail investors. The average institutional ownership in Tenaya Therapeutics's industry, Biotech Stocks , is 307.10%, which Tenaya Therapeutics falls below.

Who owns the most shares of Tenaya Therapeutics?

Tenaya Therapeutics’s largest shareholders are Column group (9.4M shares, 10.91%), Blackrock (4.07M shares, 5.03%), and Vanguard group (3.27M shares, 3.80%). Together, they hold 19.74% of Tenaya Therapeutics’s total shares outstanding.

Does Blackrock own Tenaya Therapeutics?

Yes, BlackRock owns 5.03% of Tenaya Therapeutics, totaling 4.07M shares as of Jun 2024. This represents 0.00% of BlackRock's total assets, with a market value of 12.63M$. In the last quarter, BlackRock decreased its holdings by -627K shares, a -13.34% change.

Who is Tenaya Therapeutics’s biggest shareholder by percentage of total assets invested?

Column group is Tenaya Therapeutics’s biggest shareholder by percentage of total assets invested, with 24.12% of its assets in 9.4M Tenaya Therapeutics shares, valued at 13.44M$.

Who is the top mutual fund holder of Tenaya Therapeutics shares?

US Small-Cap Growth II Equity Comp is the top mutual fund holder of Tenaya Therapeutics shares, with 2.66% of its total shares outstanding invested in 2.1M Tenaya Therapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis

Discover trending investment themes
Find your next best investment
Research stocks using tools